Shareholders Meetings

Share capital and voting rights*

  • Share capital: €5,036,555.00
  • Number of shares outstanding: 100,732,781
  • Total number of voting rights: 105,563,044

*As of September 30, 2026

25
Jun 2026
16:10 E.S.T.

Vote results – AGM June 25, 2026

Download the PDF file
15
Jun 2026
08:48 E.S.T.

Overview Year ending December 31st 2025 – AGM June 25, 2026

Download the PDF file
9
Jun 2026
13:23 E.S.T.

Statutory auditor’s report on the 30th resolution – AGM June 25, 2026

Download the PDF file
9
Jun 2026
13:22 E.S.T.

Statutory auditor’s report on the 26th and 28th resolutions – AGM June 25, 2026

Download the PDF file
9
Jun 2026
13:22 E.S.T.

Statutory auditor’s report on the 27th and 28th resolutions – AGM June 25, 2026

Download the PDF file
9
Jun 2026
13:21 E.S.T.

Statutory auditor’s report on the 19th and 24th resolutions – AGM June 25, 2026

Download the PDF file
9
Jun 2026
13:21 E.S.T.

Statutory auditor’s report on the 20th to 24th resolutions – AGM June 25, 2026

Download the PDF file
9
Jun 2026
13:20 E.S.T.

Statutory auditor’s report on the 16th and 24th resolutions – AGM June 25, 2026

Download the PDF file
9
Jun 2026
13:20 E.S.T.

Statutory auditor’s report on the 18th and 24th resolutions – AGM June 25, 2026

Download the PDF file
9
Jun 2026
13:19 E.S.T.

Statutory auditor’s report on the 11th resolution – AGM June 25, 2026

Download the PDF file

Get updates

Get the latest on gene-editing innovation, financial and business news from Cellectis with our email alert service.

Subscribe now